Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting · NCT06168851 · Registry updated 2025-11-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP) | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Recruiting | Phase 2 | 2025-11-28 | NCT06168851 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Children's Hospital | 30 |
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
| Tianjin Children's Hospital | 8 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese Academy of Medical Science and Blood Disease Hospital | Tianjin | China | 15 |